Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2021 Aug:153:257-259.
doi: 10.1016/j.ejca.2021.05.007. Epub 2021 May 24.

Adherence to COVID-19 vaccines in cancer patients: promote it and make it happen!

Giuseppe Curigliano  1 , Alexander M M Eggermont  2
Affiliations
Editorial

Adherence to COVID-19 vaccines in cancer patients: promote it and make it happen!

Giuseppe Curigliano et al. Eur J Cancer. 2021 Aug.
No abstract available

Keywords: COVID 19; Cancer patients; SARS-CoV-2; Vaccine.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest statement GC has received honoraria from Pfizer, Novartis, Lilly, Roche; fees for expert testimony and medical education from Pfizer; and has participated in advisory boards for Pfizer, Roche, Lilly, Novartis, Seattle Genetics, Celltrion. All the declarations are outside the submitted work. AMME has received over the last 3 years honoraria for Scientific Advisory Board and/or Independent Data Monitoring Committee membership from Biocad, BioInvent, BioNTech, BMS, CatalYm, Ellipses, Forbion, GSK, IO Biotech, ISA Pharmaceuticals, Merck/MSD, Nektar, Novartis, Pfizer, Regeneron, Roche, Sellas, SkylineDx. All the declarations are outside the submitted work.

Comment on

References

    1. The Lancet Oncology COVID-19 and cancer: 1 year on. Lancet Oncol. 2021 Apr;22(4):411. doi: 10.1016/S1470-2045(21)00148-0. PMID: 33794199; PMCID: PMC8007133. - DOI - PMC - PubMed
    1. Corti C., Curigliano G. SARS-CoV-2 vaccines and cancer patients. Ann Oncol. 2021 Apr;32(4):569–571. doi: 10.1016/j.annonc.2020.12.019. Epub 2021 Jan 12. PMID: 33450404; PMCID: PMC7831848. - DOI - PMC - PubMed
    1. Gnanvi J.E., Salako K.V., Kotanmi G.B., Glèlè Kakaï R. On the reliability of predictions on Covid-19 dynamics: a systematic and critical review of modelling techniques. Infect Dis Model. 2021;6:258–272. doi: 10.1016/j.idm.2020.12.008. Epub 2021 Jan 12. PMID: 33458453; PMCID: PMC7802527. - DOI - PMC - PubMed
    1. Monin L., Laing A.G., Muñoz-Ruiz M., McKenzie D.R., Del Molino Del Barrio I., Alaguthurai T., et al. Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study. Lancet Oncol. 2021 Apr 27;S1470–2045(21):213–218. - PMC - PubMed
    1. Marra A., Generali D., Zagami P., Cervoni V., Gandini S., Venturini S., et al. Seroconversion in patients with cancer and oncology health care workers infected by SARS-CoV-2. Ann Oncol. 2021 Jan;32(1):113–119. - PMC - PubMed

Substances